Stem cell secretion therapy for thinking recovery after stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a therapy made from stem cell secretions can help improve memory and thinking after an ischemic stroke. It is for people who had a clot-related stroke in the past 3 months and now have mild to moderate cognitive issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- Your stroke was caused by a clot (ischemic) and happened between 7 days and 3 months ago.
- You have mild to moderate memory or thinking problems from the stroke.
- You are medically stable and able to do basic thinking tests.
- You do not have other serious health issues like active infection, cancer, or severe organ failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of proteins from stem cells and a safe brain stimulation method to help people recover movement after a stroke. It may improve recovery when started 1 to 6 months after a first stroke.
This trial tests whether a special type of stem cell (from umbilical cord) can help people recover after a recent ischemic stroke. It aims to see if this treatment can improve movement and reduce disability.
This study tests whether a noninvasive brain stimulation treatment, combined with rehabilitation, can improve thinking and other “neurocognition” problems after a recent stroke. It may help people whose thinking has been affected by stroke within the past month.
This trial tests whether a nasal spray made from stem cell particles can help people recover after an ischemic stroke. It is for adults who had a stroke within the last two weeks and did not receive clot-busting treatment.
This trial tests whether a patient's own bone marrow stem cells, given through a vein, can help improve recovery after a stroke. It is for people who had a moderate stroke 3 to 12 months ago and still have some disability.
This study tests an under-the-tongue tablet (edaravone dexborneol) to help thinking and memory problems that can happen after an ischemic stroke. It may help people who recently had a stroke and now have trouble with attention, memory, or planning.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.